相关实验视频

Updated: Jun 29, 2025

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
10:41

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis

Published on: December 15, 2023

1.8K

内镜十二指肠粘膜切除:糖尿病治疗的未来?

Giovanni Musso1, Maurizio Cassader2, Roberto Gambino2

  • 1MECAU, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.

Trends in molecular medicine
|March 29, 2024
PubMed
概括

十二指甲粘膜切除 (DMA) 为2型糖尿病提供了一种新的治疗方法. 这种内镜手术用健康的组织取代功能障碍的十二指肠内,显示出糖尿病管理的前景.

关键词:
这就是 ReCET 的处方.十二指甲膜粘膜的重新表面化电穿孔疗法是一种电穿孔疗法.再细胞化是重细胞化.

更多相关视频

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

528
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

566

相关概念视频

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321